^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TTX-030

    i
    Other names: TTX-030
    Associations
    News
    Trials
    Company:
    AbbVie, Trishula Therap
    Drug class:
    CD39 inhibitor
    Related drugs:
    Associations
    News
    Trials